Business Description
BlackRock Health Sciences Trust II
NAICS : 523920
SIC : 6799
ISIN : US09260E1055
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.98 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 6/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -60 | |||||
3-Year EPS without NRI Growth Rate | -60.3 | |||||
3-Year Book Growth Rate | -16.5 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.13 | |||||
9-Day RSI | 32.99 | |||||
14-Day RSI | 31.91 | |||||
6-1 Month Momentum % | 21.15 | |||||
12-1 Month Momentum % | -1.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 9.31 | |||||
Forward Dividend Yield % | 7.4 | |||||
5-Year Yield-on-Cost % | 9.2 | |||||
3-Year Average Share Buyback Ratio | 1.9 | |||||
Shareholder Yield % | 12.43 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 97.7 | |||||
FCF Margin % | 314.37 | |||||
ROE % | 3.48 | |||||
ROA % | 3.38 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 22.41 | |||||
PB Ratio | 0.82 | |||||
Price-to-Tangible-Book | 0.82 | |||||
Price-to-Free-Cash-Flow | 6.95 | |||||
Price-to-Operating-Cash-Flow | 6.95 | |||||
EV-to-Revenue | 25.85 | |||||
EV-to-FCF | 8.23 | |||||
FCF Yield % | 14.4 |